Provider: Nature Publishing Group Content: application/x-research-info-systems TY - GEN AU - Vogelstein, B. AU - Kinzler, K. W. TI - The Genetic Basis of Human Cancer PY - 2002/// ER - TY - JOUR AU - Balmain, A. AU - Gray, J. AU - Ponder, B. TI - The genetics and genomics of cancer JO - Nature Genet. PY - 2003/// VL - 33 SP - 238 EP - 244 M3 - 10.1038/ng1107 N1 - 10.1038/ng1107 UR - http://dx.doi.org/10.1038/ng1107 ER - TY - JOUR AU - Popescu, N. C. TI - Comprehensive genetic analysis of cancer cells JO - J. Cell. Mol. Med. PY - 2000/// VL - 4 SP - 151 EP - 163 ER - TY - JOUR TI - Initial sequencing and analysis of the human genome JO - Nature PY - 2001/// VL - 409 SP - 860 EP - 921 M3 - 10.1038/35057062 N1 - 10.1038/35057062 UR - http://dx.doi.org/10.1038/35057062 ER - TY - JOUR AU - Venter, J. C. TI - The sequence of the human genome JO - Science PY - 2001/// VL - 291 SP - 1304 EP - 1351 M3 - 10.1126/science.1058040 N1 - 10.1126/science.1058040 UR - http://dx.doi.org/10.1126/science.1058040 ER - TY - JOUR AU - Druker, B. J. TI - STI571 (Gleevec) as a paradigm for cancer therapy JO - Trends Mol. Med. PY - 2002/// VL - 8 SP - EP - M3 - 10.1016/S1471-4914(02)02305-5 N1 - 10.1016/S1471-4914(02)02305-5 UR - http://dx.doi.org/10.1016/S1471-4914(02)02305-5 ER - TY - JOUR AU - Kim, J. A. TI - Targeted therapies for the treatment of cancer JO - Am. J. Surg. PY - 2003/// VL - 186 SP - 264 EP - 268 M3 - 10.1016/S0002-9610(03)00212-5 N1 - 10.1016/S0002-9610(03)00212-5 UR - http://dx.doi.org/10.1016/S0002-9610(03)00212-5 ER - TY - JOUR AU - Smith, I. E. TI - Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies JO - Anticancer Drugs PY - 2001/// SP - S3 EP - S10 ER - TY - JOUR AU - Salgaller, M. TI - Technology evaluation: bevacizumab, Genentech/Roche JO - Curr. Opin. Mol. Ther. PY - 2003/// VL - 5 SP - 657 EP - 667 ER - TY - JOUR AU - Schadt, E. E. AU - Monks, S. A. AU - Friend, S. H. TI - A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets JO - Biochem. Soc. Trans. PY - 2003/// VL - 31 SP - 437 EP - 443 M3 - 10.1042/BST0310437 N1 - 10.1042/BST0310437 UR - http://dx.doi.org/10.1042/BST0310437 ER - TY - JOUR AU - Fischer, O. M. AU - Streit, S. AU - Hart, S. AU - Ullrich, A. TI - Herceptin and Gleevec JO - Curr. Opin. Chem. Biol. PY - 2003/// VL - 7 SP - 490 EP - 495 M3 - 10.1016/S1367-5931(03)00082-6 N1 - 10.1016/S1367-5931(03)00082-6 UR - http://dx.doi.org/10.1016/S1367-5931(03)00082-6 ER - TY - JOUR AU - Davies, H. TI - Mutations of the BRAF gene in human cancer JO - Nature PY - 2002/// VL - 417 SP - 949 EP - 954 M3 - 10.1038/nature00766 N1 - 10.1038/nature00766 UR - http://dx.doi.org/10.1038/nature00766 ER - TY - JOUR AU - Bardelli, A. TI - Mutational analysis of the tyrosine kinome in colorectal cancers JO - Science PY - 2003/// VL - 300 SP - EP - 949 M3 - 10.1126/science.1082596 N1 - 10.1126/science.1082596 UR - http://dx.doi.org/10.1126/science.1082596 ER - TY - JOUR AU - Samuels, Y. TI - High frequency of mutations of the PIK3CA gene in human cancers JO - Science PY - 2004/// VL - 304 SP - EP - 554 M3 - 10.1126/science.1096502 N1 - 10.1126/science.1096502 UR - http://dx.doi.org/10.1126/science.1096502 ER - TY - JOUR AU - Hilgenfeld, E. TI - Spectral karyotyping in cancer cytogenetics JO - Methods Mol. Med. PY - 2002/// VL - 68 SP - 29 EP - 44 ER - TY - JOUR AU - Lucito, R. TI - Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation JO - Genome Res. PY - 2003/// VL - 13 SP - 2291 EP - 2305 M3 - 10.1101/gr.1349003 N1 - 10.1101/gr.1349003 UR - http://dx.doi.org/10.1101/gr.1349003 ER - TY - JOUR AU - Cowell, J. K. AU - Nowak, N. J. TI - High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization JO - Adv. Cancer Res. PY - 2003/// VL - 90 SP - 91 EP - 125 M3 - 10.1016/S0065-230X(03)90003-0 N1 - 10.1016/S0065-230X(03)90003-0 UR - http://dx.doi.org/10.1016/S0065-230X(03)90003-0 ER - TY - JOUR AU - Liang, G. TI - DNA methylation differences associated with tumor tissues identified by genome scanning analysis JO - Genomics PY - 1998/// VL - 53 SP - 260 EP - 268 M3 - 10.1006/geno.1998.5502 N1 - 10.1006/geno.1998.5502 UR - http://dx.doi.org/10.1006/geno.1998.5502 ER - TY - JOUR AU - Cottrell, S. E. TI - A real-time PCR assay for DNA-methylation using methylation-specific blockers JO - Nucleic Acids Res. PY - 2004/// VL - 32 SP - e10 EP - e10 M3 - 10.1093/nar/gnh008 N1 - 10.1093/nar/gnh008 UR - http://dx.doi.org/10.1093/nar/gnh008 ER - TY - JOUR AU - Greshock, J. TI - 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis JO - Genome Res. PY - 2004/// VL - 14 SP - 179 EP - 187 M3 - 10.1101/gr.1847304 N1 - 10.1101/gr.1847304 UR - http://dx.doi.org/10.1101/gr.1847304 ER - TY - JOUR AU - Wang, T. L. TI - Digital karyotyping JO - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 16156 EP - 16161 M3 - 10.1073/pnas.202610899 N1 - 10.1073/pnas.202610899 UR - http://dx.doi.org/10.1073/pnas.202610899 ER - TY - JOUR AU - Wang, T. L. TI - Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients JO - Proc. Natl Acad. Sci. USA PY - 2004/// VL - 101 SP - 3089 EP - 3094 M3 - 10.1073/pnas.0308716101 N1 - 10.1073/pnas.0308716101 UR - http://dx.doi.org/10.1073/pnas.0308716101 ER - TY - JOUR AU - Volik, S. TI - End-sequence profiling: sequence-based analysis of aberrant genomes JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 7696 EP - 7701 M3 - 10.1073/pnas.1232418100 N1 - 10.1073/pnas.1232418100 UR - http://dx.doi.org/10.1073/pnas.1232418100 ER - TY - JOUR AU - Beroud, C. AU - Soussi, T. TI - UMD-p53 database: New mutations and analysis tools JO - Hum. Mutat. PY - 2003/// VL - 21 SP - 176 EP - 181 M3 - 10.1002/humu.10187 N1 - 10.1002/humu.10187 UR - http://dx.doi.org/10.1002/humu.10187 ER - TY - JOUR AU - Futreal, P. A. TI - A census of human cancer genes JO - Nature Rev. Cancer PY - 2004/// VL - 4 SP - 177 EP - 183 M3 - 10.1038/nrc1299 N1 - 10.1038/nrc1299 UR - http://dx.doi.org/10.1038/nrc1299 ER - TY - JOUR AU - Ramaswamy, S. AU - Ross, K. N. AU - Lander, E. S. AU - Golub, T. R. TI - A molecular signature of metastasis in primary solid tumors JO - Nature Genet. PY - 2003/// VL - 33 SP - 49 EP - 54 M3 - 10.1038/ng1060 N1 - 10.1038/ng1060 UR - http://dx.doi.org/10.1038/ng1060 ER - TY - JOUR AU - Sorlie, T. TI - Repeated observation of breast tumor subtypes in independent gene expression data sets JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 8418 EP - 8423 M3 - 10.1073/pnas.0932692100 N1 - 10.1073/pnas.0932692100 UR - http://dx.doi.org/10.1073/pnas.0932692100 ER - TY - JOUR AU - Rosenwald, A. TI - Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma JO - J. Exp. Med. PY - 2003/// VL - 198 SP - 851 EP - 862 M3 - 10.1084/jem.20031074 N1 - 10.1084/jem.20031074 UR - http://dx.doi.org/10.1084/jem.20031074 ER - TY - JOUR AU - van 't Veer, L. J. TI - Expression profiling predicts outcome in breast cancer JO - Breast Cancer Res. PY - 2003/// VL - 5 SP - 57 EP - 58 M3 - 10.1186/bcr562 N1 - 10.1186/bcr562 UR - http://dx.doi.org/10.1186/bcr562 ER - TY - JOUR AU - van de Vijver, M. J. TI - A gene-expression signature as a predictor of survival in breast cancer JO - N. Engl. J. Med. PY - 2002/// VL - 347 SP - 1999 EP - 2009 M3 - 10.1056/NEJMoa021967 N1 - 10.1056/NEJMoa021967 UR - http://dx.doi.org/10.1056/NEJMoa021967 ER - TY - JOUR AU - Nutt, C. L. TI - Gene expression-based classification of malignant gliomas correlates better with survival than histological classification JO - Cancer Res. PY - 2003/// VL - 63 SP - 1602 EP - 1607 ER - TY - JOUR AU - Dyrskjot, L. TI - Identifying distinct classes of bladder carcinoma using microarrays JO - Nature Genet. PY - 2003/// VL - 33 SP - 90 EP - 96 M3 - 10.1038/ng1061 N1 - 10.1038/ng1061 UR - http://dx.doi.org/10.1038/ng1061 ER - TY - JOUR AU - Velculescu, V. E. AU - Zhang, L. AU - Vogelstein, B. AU - Kinzler, K. W. TI - Serial analysis of gene-expression JO - Science PY - 1995/// VL - 270 SP - 484 EP - 487 ER - TY - JOUR AU - Lal, A. TI - A public database for gene expression in human cancers JO - Cancer Res. PY - 1999/// VL - 59 SP - 5403 EP - 5407 ER - TY - JOUR AU - Buckhaults, P. TI - Identifying tumor origin using a gene expression-based classification map JO - Cancer Res. PY - 2003/// VL - 63 SP - 4144 EP - 4149 ER - TY - JOUR AU - Jongeneel, C. V. TI - Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 4702 EP - 4705 M3 - 10.1073/pnas.0831040100 N1 - 10.1073/pnas.0831040100 UR - http://dx.doi.org/10.1073/pnas.0831040100 ER - TY - JOUR AU - Brentani, H. TI - The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 13418 EP - 13423 M3 - 10.1073/pnas.1233632100 N1 - 10.1073/pnas.1233632100 UR - http://dx.doi.org/10.1073/pnas.1233632100 ER - TY - JOUR AU - Strausberg, R. L. TI - An international database and integrated analysis tools for the study of cancer gene expression JO - Pharmacogenomics J. PY - 2002/// VL - 2 SP - 156 EP - 164 M3 - 10.1038/sj.tpj.6500103 N1 - 10.1038/sj.tpj.6500103 UR - http://dx.doi.org/10.1038/sj.tpj.6500103 ER - TY - JOUR AU - Saha, S. TI - Using the transcriptome to annotate the genome JO - Nature Biotechnol. PY - 2002/// VL - 20 SP - 508 EP - 512 M3 - 10.1038/nbt0502-508 N1 - 10.1038/nbt0502-508 UR - http://dx.doi.org/10.1038/nbt0502-508 ER - TY - JOUR AU - Ota, T. TI - Complete sequencing and characterization of 21,243 full-length human cDNAs JO - Nature Genet. PY - 2004/// VL - 36 SP - 40 EP - 45 M3 - 10.1038/ng1285 N1 - 10.1038/ng1285 UR - http://dx.doi.org/10.1038/ng1285 ER - TY - JOUR AU - Strausberg, R. L. TI - Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences JO - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 16899 EP - 16903 M3 - 10.1073/pnas.242603899 N1 - 10.1073/pnas.242603899 UR - http://dx.doi.org/10.1073/pnas.242603899 ER - TY - JOUR AU - Xu, Q. AU - Lee, C. TI - Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences JO - Nucleic Acids Res. PY - 2003/// VL - 31 SP - 5635 EP - 5643 M3 - 10.1093/nar/gkg786 N1 - 10.1093/nar/gkg786 UR - http://dx.doi.org/10.1093/nar/gkg786 ER - TY - JOUR AU - Wang, Z. TI - Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer JO - Cancer Res. PY - 2003/// VL - 63 SP - 655 EP - 657 ER - TY - JOUR AU - Kriventseva, E. V. TI - Increase of functional diversity by alternative splicing JO - Trends Genet. PY - 2003/// VL - 19 SP - 124 EP - 128 M3 - 10.1016/S0168-9525(03)00023-4 N1 - 10.1016/S0168-9525(03)00023-4 UR - http://dx.doi.org/10.1016/S0168-9525(03)00023-4 ER - TY - JOUR AU - Strausberg, R. L. AU - Simpson, A. J. AU - Wooster, R. TI - Sequence-based cancer genomics: progress, lessons and opportunities JO - Nature Rev. Genet. PY - 2003/// VL - 4 SP - 409 EP - 418 M3 - 10.1038/nrg1085 N1 - 10.1038/nrg1085 UR - http://dx.doi.org/10.1038/nrg1085 ER - TY - JOUR AU - Drevs, J. AU - Medinger, M. AU - Schmidt-Gersbach, C. AU - Weber, R. AU - Unger, C. TI - Receptor tyrosine kinases: the main targets for new anticancer therapy JO - Curr. Drug Targets PY - 2003/// VL - 4 SP - 113 EP - 121 ER - TY - JOUR AU - Sausville, E. A. AU - Elsayed, Y. AU - Monga, M. AU - Kim, G. TI - Signal transduction [mdash] directed cancer treatments JO - Annu. Rev. Pharmacol. Toxicol. PY - 2003/// VL - 43 SP - 199 EP - 231 M3 - 10.1146/annurev.pharmtox.43.100901.135813 N1 - 10.1146/annurev.pharmtox.43.100901.135813 UR - http://dx.doi.org/10.1146/annurev.pharmtox.43.100901.135813 ER - TY - JOUR AU - Cockerill, G. S. AU - Lackey, K. E. TI - Small molecule inhibitors of the class 1 receptor tyrosine kinase family JO - Curr. Top. Med. Chem. PY - 2002/// VL - 2 SP - 1001 EP - 1010 ER - TY - JOUR AU - Wilhelm, S. AU - Chien, D. S. TI - BAY 43-9006: preclinical data JO - Curr. Pharm. Des. PY - 2002/// VL - 8 SP - 2255 EP - 2257 ER - TY - JOUR AU - Joensuu, H. AU - Dimitrijevic, S. TI - Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours JO - Ann. Med. PY - 2001/// VL - 33 SP - 451 EP - 455 ER - TY - JOUR AU - Demetri, G. D. TI - Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development JO - Hematol. Oncol. Clin. North Am. PY - 2002/// VL - 16 SP - 1115 EP - 1124 ER - TY - JOUR AU - Druker, B. TI - Imatinib mesylate in the treatment of chronic myeloid leukaemia JO - Expert Opin. Pharmacother. PY - 2003/// VL - 4 SP - 963 EP - 971 M3 - 10.1517/eoph.4.6.963.22202 N1 - 10.1517/eoph.4.6.963.22202 UR - http://dx.doi.org/10.1517/eoph.4.6.963.22202 ER - TY - JOUR AU - Tipping, A. J. AU - Melo, J. V. TI - Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies JO - Semin. Hematol. PY - 2003/// VL - 40 SP - 83 EP - 91 M3 - 10.1053/shem.2003.50047 N1 - 10.1053/shem.2003.50047 UR - http://dx.doi.org/10.1053/shem.2003.50047 ER - TY - JOUR AU - Druker, B. TI - Imatinib alone and in combination for chronic myeloid leukemia JO - Semin. Hematol. PY - 2003/// VL - 40 SP - 50 EP - 58 M3 - 10.1053/shem.2003.50000 N1 - 10.1053/shem.2003.50000 UR - http://dx.doi.org/10.1053/shem.2003.50000 ER - TY - JOUR AU - Joensuu, H. TI - Management of malignant gastrointestinal stromal tumours JO - Lancet Oncol. PY - 2002/// VL - 3 SP - 655 EP - 664 M3 - 10.1016/S1470-2045(02)00899-9 N1 - 10.1016/S1470-2045(02)00899-9 UR - http://dx.doi.org/10.1016/S1470-2045(02)00899-9 ER - TY - JOUR AU - Joensuu, H. TI - Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor JO - N. Engl. J. Med. PY - 2001/// VL - 344 SP - 1052 EP - 1056 M3 - 10.1056/NEJM200104053441404 N1 - 10.1056/NEJM200104053441404 UR - http://dx.doi.org/10.1056/NEJM200104053441404 ER - TY - JOUR TI - Clinical activity and tolerability of the multi-targeted tyrosine kinase inhibitor SU11248 in patients (pts) with metastatic gastrointestinal stromal tumor (GIST) refractory to imatinib mesylate JO - Proc. Am. Soc. Clin. Oncol. PY - 2003/// VL - 22 SP - EP - 814 ER - TY - JOUR AU - Egland, K. A. AU - Vincent, J. J. AU - Strausberg, R. AU - Lee, B. AU - Pastan, I. TI - Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 1099 EP - 1104 M3 - 10.1073/pnas.0337425100 N1 - 10.1073/pnas.0337425100 UR - http://dx.doi.org/10.1073/pnas.0337425100 ER - TY - JOUR AU - Olsson, P. AU - Motegi, A. AU - Bera, T. K. AU - Lee, B. AU - Pastan, I. TI - PRAC2: a new gene expressed in human prostate and prostate cancer JO - Prostate PY - 2003/// VL - 56 SP - 123 EP - 130 M3 - 10.1002/pros.10185 N1 - 10.1002/pros.10185 UR - http://dx.doi.org/10.1002/pros.10185 ER - TY - JOUR AU - Jager, D. TI - Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library JO - Cancer Res. PY - 2001/// VL - 61 SP - 2055 EP - 2061 ER - TY - JOUR AU - Bera, T. K. TI - NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate JO - Proc. Natl Acad. Sci. USA PY - 2004/// VL - 101 SP - 3059 EP - 3064 M3 - 10.1073/pnas.0308746101 N1 - 10.1073/pnas.0308746101 UR - http://dx.doi.org/10.1073/pnas.0308746101 ER - TY - JOUR AU - Scanlan, M. J. AU - Gure, A. O. AU - Jungbluth, A. A. AU - Old, L. J. AU - Chen, Y. T. TI - Cancer/testis antigens: an expanding family of targets for cancer immunotherapy JO - Immunol. Rev. PY - 2002/// VL - 188 SP - 22 EP - 32 M3 - 10.1034/j.1600-065X.2002.18803.x N1 - 10.1034/j.1600-065X.2002.18803.x UR - http://dx.doi.org/10.1034/j.1600-065X.2002.18803.x ER - TY - JOUR AU - Scanlan, M. J. AU - Simpson, A. J. AU - Old, L. J. TI - The cancer/testis genes: review, standardization, and commentary JO - Cancer Immun. PY - 2004/// VL - 4 SP - 1 EP - 1 ER - TY - JOUR AU - Scanlan, M. J. TI - Identification of cancer/testis genes by database mining and mRNA expression analysis JO - Int. J. Cancer PY - 2002/// VL - 98 SP - 485 EP - 492 M3 - 10.1002/ijc.10276 N1 - 10.1002/ijc.10276 UR - http://dx.doi.org/10.1002/ijc.10276 ER - TY - JOUR AU - Old, L. J. TI - Cancer/testis (CT) antigens - a new link between gametogenesis and cancer JO - Cancer Immun PY - 2001/// VL - 1 SP - 1 EP - 1 ER - TY - JOUR AU - Durrant, L. G. AU - Spendlove, I. TI - Cancer vaccines entering Phase III clinical trials JO - Expert Opin. Emerg. Drugs PY - 2003/// VL - 8 SP - 489 EP - 500 M3 - 10.1517/eoed.8.2.489.21127 N1 - 10.1517/eoed.8.2.489.21127 UR - http://dx.doi.org/10.1517/eoed.8.2.489.21127 ER - TY - JOUR AU - Jager, E. AU - Jager, D. AU - Knuth, A. TI - Antigen-specific immunotherapy and cancer vaccines JO - Int. J. Cancer PY - 2003/// VL - 106 SP - 817 EP - 820 M3 - 10.1002/ijc.11292 N1 - 10.1002/ijc.11292 UR - http://dx.doi.org/10.1002/ijc.11292 ER - TY - JOUR AU - Albanell, J. AU - Codony, J. AU - Rovira, A. AU - Mellado, B. AU - Gascon, P. TI - Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4 JO - Adv. Exp. Med. Biol. PY - 2003/// VL - 532 SP - 253 EP - 268 ER - TY - JOUR AU - Blackledge, G. AU - Averbusch, S. TI - Gefitinib (`Iressa', ZD1839) and new epidermal growth factor receptor inhibitors JO - Br. J. Cancer PY - 2004/// VL - 90 SP - 566 EP - 572 M3 - 10.1038/sj.bjc.6601550 N1 - 10.1038/sj.bjc.6601550 UR - http://dx.doi.org/10.1038/sj.bjc.6601550 ER - TY - JOUR AU - Coiffier, B. TI - Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly JO - Semin. Oncol. PY - 2003/// VL - 30 SP - 21 EP - 27 M3 - 10.1053/sonc.2003.50029 N1 - 10.1053/sonc.2003.50029 UR - http://dx.doi.org/10.1053/sonc.2003.50029 ER - TY - JOUR AU - Wannesson, L. AU - Ghielmini, M. TI - Overview of antibody therapy in B-cell non-Hodgkin's lymphoma JO - Clin. Lymphoma PY - 2003/// VL - 4 SP - S5 EP - S12 ER - TY - JOUR AU - Jain, R. K. TI - Tumor angiogenesis and accessibility: role of vascular endothelial growth factor JO - Semin. Oncol. PY - 2002/// VL - 29 SP - 3 EP - 9 M3 - 10.1053/sonc.2002.37265 N1 - 10.1053/sonc.2002.37265 UR - http://dx.doi.org/10.1053/sonc.2002.37265 ER - TY - JOUR AU - Milenic, D. E. AU - Brechbiel, M. W. TI - Targeting of radio-isotopes for cancer therapy JO - Cancer Biol. Ther. PY - 2004/// VL - 3 SP - EP - ER - TY - JOUR AU - Damle, N. K. AU - Frost, P. TI - Antibody-targeted chemotherapy with immunoconjugates of calicheamicin JO - Curr. Opin. Pharmacol. PY - 2003/// VL - 3 SP - 386 EP - 390 M3 - 10.1016/S1471-4892(03)00083-3 N1 - 10.1016/S1471-4892(03)00083-3 UR - http://dx.doi.org/10.1016/S1471-4892(03)00083-3 ER - TY - JOUR AU - McCormick, F. TI - Cancer-specific viruses and the development of ONYX-015 JO - Cancer Biol. Ther. PY - 2003/// VL - 2 SP - s157 EP - s160 ER - TY - JOUR AU - Tong, A. W. AU - Zhang, Y. A. AU - Cunningham, C. AU - Maples, P. AU - Nemunaitis, J. TI - Potential clinical application of antioncogene ribozymes for human lung cancer JO - Clin. Lung Cancer PY - 2001/// VL - 2 SP - 220 EP - 226 ER - TY - JOUR AU - Moon, C. AU - Oh, Y. AU - Roth, J. A. TI - Current status of gene therapy for lung cancer and head and neck cancer JO - Clin. Cancer Res. PY - 2003/// VL - 9 SP - 5055 EP - 5067 ER - TY - JOUR AU - McNeish, I. A. AU - Bell, S. J. AU - Lemoine, N. R. TI - Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes JO - Gene Ther. PY - 2004/// VL - 11 SP - 497 EP - 503 M3 - 10.1038/sj.gt.3302238 N1 - 10.1038/sj.gt.3302238 UR - http://dx.doi.org/10.1038/sj.gt.3302238 ER - TY - JOUR AU - Torrance, C. J. AU - Agrawal, V. AU - Vogelstein, B. AU - Kinzler, K. W. TI - Use of isogenic human cancer cells for high-throughput screening and drug discovery JO - Nature Biotechnol. PY - 2001/// VL - 19 SP - 940 EP - 945 M3 - 10.1038/nbt1001-940 N1 - 10.1038/nbt1001-940 UR - http://dx.doi.org/10.1038/nbt1001-940 ER - TY - JOUR AU - Strausberg, R. L. AU - Schreiber, S. L. TI - From knowing to controlling: a path from genomics to drugs using small molecule probes JO - Science PY - 2003/// VL - 300 SP - 294 EP - 295 M3 - 10.1126/science.1083395 N1 - 10.1126/science.1083395 UR - http://dx.doi.org/10.1126/science.1083395 ER - TY - JOUR AU - Koehler, A. N. AU - Shamji, A. F. AU - Schreiber, S. L. TI - Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis JO - J. Am. Chem. Soc. PY - 2003/// VL - 125 SP - 8420 EP - 8421 M3 - 10.1021/ja0352698 N1 - 10.1021/ja0352698 UR - http://dx.doi.org/10.1021/ja0352698 ER - TY - JOUR AU - Zerhouni, E. TI - The NIH Roadmap JO - Science PY - 2003/// VL - 302 SP - 63 EP - 72 M3 - 10.1126/science.1091867 N1 - 10.1126/science.1091867 UR - http://dx.doi.org/10.1126/science.1091867 ER - TY - JOUR AU - Collins, F. S. AU - Morgan, M. AU - Patrinos, A. TI - The Human Genome Project: lessons from large-scale biology JO - Science PY - 2003/// VL - 300 SP - 286 EP - 290 M3 - 10.1126/science.1084564 N1 - 10.1126/science.1084564 UR - http://dx.doi.org/10.1126/science.1084564 ER - TY - JOUR AU - Newman, D. J. AU - Cragg, G. M. AU - Snader, K. M. TI - Natural products as sources of new drugs over the period 1981-2002 JO - J. Nat. Prod. PY - 2003/// VL - 66 SP - 1022 EP - 1037 M3 - 10.1021/np030096l N1 - 10.1021/np030096l UR - http://dx.doi.org/10.1021/np030096l ER - TY - JOUR AU - Myers, N. AU - Mittermeier, R. A. AU - Mittermeier, C. G. AU - da Fonseca, G. A. AU - Kent, J. TI - Biodiversity hotspots for conservation priorities JO - Nature PY - 2000/// VL - 403 SP - 853 EP - 858 M3 - 10.1038/35002501 N1 - 10.1038/35002501 UR - http://dx.doi.org/10.1038/35002501 ER - TY - JOUR AU - Brizuela, L. AU - Richardson, A. AU - Marsischky, G. AU - Labaer, J. TI - The FLEXGene repository: Exploiting the fruits of the genome projects by creating a needed resource to face the challenges of the post-genomic era JO - Arch. Med. Res. PY - 2002/// VL - 33 SP - 318 EP - 324 M3 - 10.1016/S0188-4409(02)00372-7 N1 - 10.1016/S0188-4409(02)00372-7 UR - http://dx.doi.org/10.1016/S0188-4409(02)00372-7 ER - TY - JOUR AU - Kretzschmar, T. AU - von Ruden, T. TI - Antibody discovery: phage display JO - Curr. Opin. Biotechnol. PY - 2002/// VL - 13 SP - 598 EP - 602 M3 - 10.1016/S0958-1669(02)00380-4 N1 - 10.1016/S0958-1669(02)00380-4 UR - http://dx.doi.org/10.1016/S0958-1669(02)00380-4 ER - TY - JOUR AU - Brekke, O. H. AU - Loset, G. A. TI - New technologies in therapeutic antibody development JO - Curr. Opin. Pharmacol. PY - 2003/// VL - 3 SP - 544 EP - 550 M3 - 10.1016/j.coph.2003.05.002 N1 - 10.1016/j.coph.2003.05.002 UR - http://dx.doi.org/10.1016/j.coph.2003.05.002 ER - TY - JOUR AU - Pasqualini, R. AU - Ruoslahti, E. TI - Organ targeting in vivo using phage display peptide libraries JO - Nature PY - 1996/// VL - 380 SP - 364 EP - 366 M3 - 10.1038/380364a0 N1 - 10.1038/380364a0 UR - http://dx.doi.org/10.1038/380364a0 ER - TY - JOUR AU - Ellerby, H. M. TI - Anti-cancer activity of targeted pro-apoptotic peptides JO - Nature Med. PY - 1999/// VL - 5 SP - 1032 EP - 1038 M3 - 10.1038/12469 N1 - 10.1038/12469 UR - http://dx.doi.org/10.1038/12469 ER - TY - JOUR AU - Scott, A. M. TI - A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer JO - Clin. Cancer Res. PY - 2003/// VL - 9 SP - 1639 EP - 1647 ER - TY - JOUR AU - Welt, S. TI - Phase I study of anticolon cancer humanized antibody A33 JO - Clin. Cancer Res. PY - 2003/// VL - 9 SP - 1338 EP - 1346 ER - TY - JOUR AU - Scott, A. M. TI - Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial JO - J. Clin. Oncol. PY - 2001/// VL - 19 SP - 3967 EP - 3987 ER - TY - JOUR AU - Jager, E. TI - Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers JO - Proc. Natl Acad. Sci. USA PY - 2000/// VL - 97 SP - 12198 EP - 12203 M3 - 10.1073/pnas.220413497 N1 - 10.1073/pnas.220413497 UR - http://dx.doi.org/10.1073/pnas.220413497 ER - TY - JOUR AU - Atanackovic, D. TI - Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients JO - J. Immunol. PY - 2004/// VL - 172 SP - 3289 EP - 3296 ER - TY - JOUR AU - Duyk, G. TI - Attrition and translation JO - Science PY - 2003/// VL - 302 SP - 603 EP - 605 M3 - 10.1126/science.1090521 N1 - 10.1126/science.1090521 UR - http://dx.doi.org/10.1126/science.1090521 ER - TY - JOUR AU - Rapisarda, A. TI - Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway JO - Cancer Res. PY - 2002/// VL - 62 SP - 4316 EP - 4324 ER -